Evidence map›Paper›PMID 29755691›Full record

ArticleOncotarget2018

Coffee consumption is not associated with ovarian cancer risk: a dose-response meta-analysis of prospective cohort studies.

Massimiliano Berretta, Agnieszka Micek, Alessandra Lafranconi, Sabrina Rossetti, Raffaele Di Francia, Paolo De Paoli, Paola Rossi, Gaetano Facchini

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Prevention of Epithelial Ovarian Cancer.Cold Spring Harbor perspectives in medicine · 2023
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Massimiliano BerrettaDepartment of Medical Oncology, National Cancer Institute-IRCCS, Aviano, Italy.
Agnieszka MicekDepartment of Epidemiology and Population Studies, Jagiellonian University Medical College, Krakow, Poland.
Alessandra LafranconiThe Research Centre on Public Health, University Milano-Bicocca, Milan, Italy.
Sabrina RossettiDepartmental Unit of Experimental Uro-Andrological Clinical Oncology, Department of Uro-Gynecological Oncology, Istituto Nazionale Tumori Fondazione G. Pascale-IRCCS, Naples, Italy.
Raffaele Di FranciaHematology-Oncology and Stem Cell Transplantation Unit, National Cancer Institute, Fondazione G. Pascale IRCCS, Naples, Italy.
Paolo De PaoliScientific Directorate, National Cancer Institute, Aviano, Italy.
Paola RossiDepartment of Biology and Biotechnology, L. Spallanzani University of Pavia, Pavia, Italy.
Gaetano FacchiniDepartmental Unit of Experimental Uro-Andrological Clinical Oncology, Department of Uro-Gynecological Oncology, Istituto Nazionale Tumori Fondazione G. Pascale-IRCCS, Naples, Italy.
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITJagiellonian University · PLUniversity of Milano-Bicocca · ITUniversity of Pavia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCoffee consumption has been associated with numerous cancers, but evidence on ovarian cancer risk is controversial. Therefore, we performed a meta-analysis on prospective cohort studies in order to review the evidence on coffee consumption and risk of ovarian cancer.

methodsStudies were identified through searching the PubMed and MEDLINE databases up to March 2017. Risk estimates were retrieved from the studies, and dose-response analysis was modelled by using restricted cubic splines. Additionally, a stratified analysis by menopausal status was performed.

resultsA total of 8 studies were eligible for the dose-response meta-analysis. Studies included in the analysis comprised 787,076 participants and 3,541 ovarian cancer cases. The results showed that coffee intake was not associated with ovarian cancer risk (RR = 1.06, 95% CI: 0.89, 1.26). Stratified and subgroup analysis showed consisted results.

conclusionsThis comprehensive meta-analysis did not find evidence of an association between the consumption of coffee and risk of ovarian cancer.

Indexed as

coffeecohort studiesmeta-analysisovarian cancerpostmenopausal

Identifiers

PMID29755691
PMCPMC5945528
OpenAlexW2801209344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.